CRWS
Crown Crafts, Inc.
CRWS has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
CRWS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CRWS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CRWS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.2x | $2.43 | — |
| Cheap | 7.2x | $3.39 | +39% |
| Fair | 9.9x | $4.65 | +91% |
| Expensive | 12x | $5.59 | +130% |
Historical ranges are pointers, not guarantees.
CRWS's PE is in its cheap range at 5.2x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CRWS Forward outlook
There aren't enough analyst estimates for CRWS to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CRWS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.47 | +$1.41 |
| Q2 2026 | $0.46 | +$1.43 |
| Q1 2026 | $0.17 | +$1.07 |
| Q4 2025 | -$0.89 | -487% |
| Q3 2025 | -$0.94 | -403% |
| Q2 2025 | -$0.97 | -337% |
| Q1 2025 | -$0.90 | -288% |
| Q4 2024 | $0.23 | -52% |
CRWS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CRWS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -20% |
| Q2 2026 | $16.8M | +8.3% |
| Q1 2026 | $22.4M | -3.7% |
| Q4 2025 | $20.7M | -11% |
| Q3 2025 | $23.7M | -3.1% |
| Q2 2025 | $15.5M | -4.5% |
| Q1 2025 | $23.2M | +2.9% |
| Q4 2024 | $23.4M | -1.9% |
CRWS's revenue has slid since its 2022 peak: $19M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.4 points |
| Q2 2026 | 17% | +24 points |
| Q1 2026 | 2.4% | +63 points |
| Q4 2025 | -0.5% | -7.8 points |
| Q3 2025 | 7.9% | +1.7 points |
| Q2 2025 | -7.8% | -5.9 points |
| Q1 2025 | -61% | -67 points |
| Q4 2024 | 7.3% | -2.5 points |
CRWS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CRWS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CRWS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.4M | +$6.4M |
| Q2 2026 | $5.4M | +3.7% |
| Q1 2026 | $926K | -65% |
| Q4 2025 | $2.3M | +$2.6M |
| Q3 2025 | -$1M | +$155K |
| Q2 2025 | $5.2M | -33% |
| Q1 2025 | $2.6M | -8.5% |
| Q4 2024 | -$220K | +$451K |
CRWS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CRWS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 5.3x | High |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 1.2x | Healthy |
CRWS's net debt is less than a year of its operating earnings (EBITDA), down from 3.0 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CRWS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.8 | Neutral |
| Stochastic | 18.4 | Oversold |
CRWS's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CRWS PE vs Consumer Cyclical Sector
| Metric | CRWS | Sector median | Relative |
|---|---|---|---|
| PE | 5.2x | 18x | 71% below |
| PE % | 0 | 47 | 47 pts below |
CRWS is trading at 5.2x earnings, a 71% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CRWS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 0.4% below |
| 20 week MA | $2.70 | 10% below |
| 50 week MA | $2.76 | 12% below |
| 100 week MA | $3.05 | 20% below |
| 200 week MA | $4.06 | 40% below |
CRWS is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CRWS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.10 | $7.15 | +17% |
| 2021 | $7.15 | $7.04 | -1.5% |
| 2022 | $7.04 | $5.30 | -25% |
| 2023 | $5.30 | $4.96 | -6.4% |
| 2024 | $4.96 | $4.51 | -9.1% |
| 2025 | $4.51 | $2.67 | -41% |
| 2026 YTD | $2.67 | $2.43 | -9% |
CRWS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.